AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

LaVoieHealthScience Reports on First Thought Leadership Panel, An Unvarnished Look at JPM Week

January 2, 2020 GMT

BOSTON--(BUSINESS WIRE)--Jan 2, 2020--

LaVoieHealthScience (LHS), a leading strategic communications firm dedicated to advancing health and science innovation, reported today on the agency’s first annual panel held on December 19 in Cambridge, Massachusetts, entitled, An Unvarnished Look at JPM Week 2020. Today, JPM Week brings together the largest group of industry, private and public company investors as well as business partners in one place to discuss the business of science and innovation, with a keen eye toward improving lives of patients and caregivers. The focus of the panel was to discuss the unpublished truths of attending and making the most of the yearly conference, increasing return on investment.

Moderated by LHS CEO, Donna L. LaVoie, panelists included Chris Garabedian, CEO of Xontogeny LLC and Portfolio Manager, Venture for Perceptive Advisors; Daphne Zohar, CEO and founder, PureTech Health; Milenko Cicmil, Vice President of Global Innovation & Partnering at Ipsen Biopharmaceuticals; and Jon Civitarese, Managing Director, Investment Banking, SVB Leerink LLC. The panel discussion covered JPMorgan history, decision tree for attending JPM Week by type of company, various venues – events, luncheons, cocktail parties, one-on-one meetings, meeting-making tools, how to best prepare, highlights and low lights of 2019, as well as 2020 predictions.

“Despite the investor, business development and licensing focus of JPM Week (also known as Biotech Week), the true winners should be patients, and JPM Week is often the first stop for healthcare pioneers who are striving to bring lifesaving medical innovation to the marketplace,” said Donna L. LaVoie. “Our panelists brought tremendous insight into this process, based on years of experience in attending JPM Week with a focus on critical fundraising, licensing, news flow and meeting colleagues.”

Panelists anticipated a robust 2020 financing market for healthcare and biotech companies. This is evidenced by the record increases of the 38 VC-backed “unicorns,” currently valued at more than $70 Billion, as well as a number of mega-round private financings.

Donna L. LaVoie commented, “Our panelists were bullish on 2020. As reported recently in BioWorld, the biopharma sector scored approval of 48 new medicines in 2019, an above average number. Our panelists indicated that this bodes for a strong follow-on offering and IPO market in first half of 2020.”

Panelists brought top tips and advice to company executives as they plan for JPM Week in 2020 and beyond:

Panelists encouraged new thinking around this yearly industry event, given the high cost of hotels, travel, meeting rooms, etc., and suggested Massachusetts as a natural future venue for meetings, given the proximity to investors, academic centers, pharma and biotech companies, and the media.

“Our panelists are calling for more careful use of time and better efficiency, no matter the size of company attending JPM Week,” said Donna L. LaVoie. “The value of this meeting will more than likely shift as new thinking evolves around how best to kick off the new year, meet investors, media and partners and achieve business goals.”

Link to Full Event Audio Recording

About LaVoieHealthScience
LaVoieHealthScience partners with leading health and science brands to build value for their companies, attract capital and reach key stakeholders through integrated communications, access and marketing. The firm provides public relations, investor relations and marketing consulting to build recognition and increase sales and value for health science innovations. The agency has received over 30 awards in recognition of the work it has done for its health and science industry-leading clients and was inducted in the 2018 Inc. 5000 Hall of Fame List of Fastest Growing Private Companies, ranked on the O’Dwyer’s list of 2019 Healthcare Public Relations Firms, PR Week’s list of 2019 Top Agencies and Boston Business Journal’s list of Largest Public Relations Firms in Massachusetts.

View source version on businesswire.com:https://www.businesswire.com/news/home/20200102005459/en/

CONTACT: Agency and Media:

Katie Gallagher

Account Manager, PR and Marketing

617-792-3937

kgallagher@lavoiehealthscience.com

KEYWORD: CALIFORNIA MASSACHUSETTS UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: FINANCE PUBLIC RELATIONS/INVESTOR RELATIONS COMMUNICATIONS PROFESSIONAL SERVICES OTHER HEALTH BIOTECHNOLOGY GENERAL HEALTH HEALTH SCIENCE OTHER SCIENCE

SOURCE: LaVoieHealthScience

Copyright Business Wire 2020.

PUB: 01/02/2020 01:00 PM/DISC: 01/02/2020 01:01 PM

http://www.businesswire.com/news/home/20200102005459/en